1.20
Lite Strategy Inc stock is traded at $1.20, with a volume of 91,504.
It is up +4.35% in the last 24 hours and up +1.69% over the past month.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
See More
Previous Close:
$1.15
Open:
$1.16
24h Volume:
91,504
Relative Volume:
0.27
Market Cap:
$43.63M
Revenue:
$65.30M
Net Income/Loss:
$-39.70M
P/E Ratio:
-0.6908
EPS:
-1.7372
Net Cash Flow:
$-12.17M
1W Performance:
+5.26%
1M Performance:
+1.69%
6M Performance:
-43.66%
1Y Performance:
+0.00%
Lite Strategy Inc Stock (LITS) Company Profile
Name
Lite Strategy Inc
Sector
Industry
Phone
858-369-7100
Address
9920 PACIFIC HEIGHTS BLVD, SAN DIEGO
Compare LITS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LITS
Lite Strategy Inc
|
1.20 | 41.82M | 65.30M | -39.70M | -12.17M | -1.7372 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Lite Strategy Inc Stock (LITS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Downgrade | Laidlaw | Buy → Hold |
| Mar-25-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-25-22 | Downgrade | Stifel | Buy → Hold |
| Mar-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-03-22 | Initiated | Jefferies | Buy |
| Sep-22-20 | Initiated | Alliance Global Partners | Buy |
| May-29-20 | Initiated | SunTrust | Buy |
| Dec-20-18 | Initiated | H.C. Wainwright | Buy |
| Jul-27-18 | Upgrade | Stifel | Hold → Buy |
| Jul-13-18 | Initiated | SunTrust | Buy |
| Apr-18-16 | Reiterated | Wedbush | Neutral |
| Mar-23-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Dec-18-14 | Reiterated | ROTH Capital | Buy |
| Oct-16-14 | Reiterated | ROTH Capital | Buy |
| Jul-08-14 | Resumed | Brean Capital | Buy |
| Oct-22-13 | Reiterated | Stifel | Buy |
| Apr-15-13 | Initiated | Stifel | Buy |
View All
Lite Strategy Inc Stock (LITS) Latest News
Allbirds Stock Rallies 700% On AI Pivot, But Mirrors Failed Crypto Treasury Plans - Yahoo Finance
LITS Options Volatility — NASDAQ:LITS - TradingView — Track All Markets
LITS Options Chain — NASDAQ:LITS - TradingView — Track All Markets
Complete List of HealthcareBiotechnologyBiotechnology Stocks - GuruFocus
Mid-Cap 1.5x Strategy Fund's Lumentum Holdings Inc(LITE) Holding History - GuruFocus
Belite Bio Inc (D01.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
Belite Bio Inc (D01.SG) Analyst Insights, Price Targets & Recommendations - ca.finance.yahoo.com
Lithos Group (XCNQ:LITS) PB Ratio : (As of Apr. 02, 2026) - GuruFocus
Lumentum (LITE) Expands Greensboro InP Fab For AI Lasers Is Its Capacity Strategy Evolving? - Yahoo Finance
Stock List: Research Stocks from Around the World - GuruFocus
Sow Good Inc. 2025 Annual Report: Asset-Light, Brand-Focused Growth Strategy and Risk Factors for Freeze-Dried Candy Business 47 49 50 51 52 53 58 - Minichart
LITS Technical Analysis & Stock Price Forecast - Intellectia AI
Verde Clean Fuels, Inc. 2025 Annual Report: STG+® Technology, Capital-Lite Strategy, and Key Business Risks - Minichart
Germany Stocks: Research Stocks from Germany Stock Market - GuruFocus
Verde Clean Fuils (VGAS) halts Permian project and pivots to capital-lite STG+ licensing strategy - Stock Titan
The Light Engine of AI: A Comprehensive Deep Dive into Lumentum Holdings (LITE) - FinancialContent
The $75,000 line in the sand: What it’ll take for bitcoin to go "full bull" - CoinDesk
Quest Resource Holding Corp (QRHC) Investor Presentation 2026: Asset-Light Waste Management Solutions, Financial Performance, and Growth Strategy - Minichart
Top Lite Strategy (LITS) Competitors 2026 - MarketBeat
Lite Strategy, Inc.: Fundamental Analysis and Financial Ratings | LITS | US55279B3015 - marketscreener.com
Lite Strategy, Inc.: Fundamental Analysis and Financial Ratings | MMI0 | US55279B3015 - marketscreener.com
LITE: AI-driven optical networking demand is driving record growth, capacity expansion, and new multi-billion deals - TradingView
LITS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
HighVista Strategies LLC Makes New $2.10 Million Investment in Lumentum Holdings Inc. $LITE - MarketBeat
Superperformer Pullback Lite — Strategy by MyViewLab - TradingView
LITE STRATEGY, INC. (LITS) - MSN
Lennar Leadership Shakeup Tests Asset Light Strategy After Softer Q1 Results - Yahoo Finance
Pixelworks Transforms Into Asset-Light Technology Licensing Company After Shanghai Subsidiary Sale – 2025 Financial Results and Strategy Update - Minichart
Wingstop Announces Additional $300 Million Share Repurchase Authorization - michigan.newsnetmedia.com
Stock Market Today: Dow, S&P 500, Nasdaq Futures Pare Gains Even As Trump Hints At Ending Iran-US War— Lumentum, Coherent, Oracle In Focus (UPDATED) - Benzinga
Financial Survey: Lunai Bioworks (NASDAQ:LNAI) versus Lite Strategy (NASDAQ:LITS) - Defense World
Lumentum Holdings Inc (NASDAQ:LITE) Passes Navellier's Growth Stock Screen - ChartMill
As Missiles Fly, is it Time to Buy? - Finviz
Lumentum Holdings, Inc. Trade Ideas — EUROTLX:4LITE - TradingView
The best strategy games on PC - Rock Paper Shotgun
Lumentum Holdings Inc (NASDAQ:LITE) Fits the High-Growth Momentum and Minervini Trend Template - ChartMill
Lite Strategy and ADVANZ PHARMA Compared in Critical Review - National Today
Lite Strategy (NASDAQ:LITS) vs. ADVANZ PHARMA (OTCMKTS:CXRXF) Head to Head Contrast - Defense World
MSN Money - MSN
Verde Clean Fuels, Inc. Announces Revised Strategy to Deploy Technology and Streamline Costs While Evaluating Strategic Alternatives - Bluefield Daily Telegraph
Clean-fuel firm cuts costs in half, explores strategic options - Stock Titan
Kenneth Griffin-linked funds disclose 3.9% Lite Strategy (LITS) ownership filing - Stock Titan
Lite Strategy (LITS) Launches Active Market Operations to Enhance Investor Value - GuruFocus
Lite Strategy (LITS) Enhances Value with Strategic Investments a - GuruFocus
Goldman Sachs Reduces PT on Snowflake Inc. (SNOW) Stock - Bitget
Lite Strategy, Inc. Reports Second Quarter Fiscal 2026 Financial Results and Launches Active Treasury Management Initiatives - Quiver Quantitative
LITS: Active LTC treasury strategy generated cash and funded a major share repurchase program - TradingView
Lite Strategy, Inc. SEC 10-Q Report - TradingView
Lite Strategy Reports Fiscal 2026 Second Quarter Results - GlobeNewswire
LITS: Quarterly net loss surged to $30.8M amid $26.5M LTC losses and a major strategic realignment - TradingView
Starbucks Just MIGHT Be Starting To See The (Asset) Lite Via China (Upgrade) (NASDAQ:SBUX) - Seeking Alpha
Lite Strategy Inc Stock (LITS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):